Clermont-Ferrand, May 16th, 2014 - ANS Biotech has obtained ISO 9001:2008 certification from Intertek Certification France, validating the quality and consistency of its preclinical research services and R&D programs. “The management commitment is very strong in the implantation of a system of Quality management” said Intertek’s auditor. ANS Biotech is the first global CRO specialized in pain research to achieve ISO 9001:2008 certification, reaffirming the Company's strong position as an experienced preclinical research partner for customers developing new drugs in the pain field.

"I am extremely proud of the ANS Biotech team for achieving this prestigious certification. As we continue to build our presence in worldwide markets, we are keenly focused on quality. ISO 9001:2008 certification reinforces our ability to provide our customers with the highest-quality preclinical research services while remaining focused on their needs for innovative and efficient solutions. “ said Francois Caussade, Chief Executive Officer.